文献速递咽喉与嗓音

多中心开发与验证声带麻痹体验(CoPE)——单侧声带麻痹特异性失能患者报告结局量表

Multicenter Development and Validation of the Vocal Cord Paralysis Experience (CoPE), a Patient-Reported Outcome Measure for Unilateral Vocal Fold Paralysis-Specific Disability.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2022-01-01

本研究在美国34家三级医疗中心开展调查验证,纳入613例经喉镜确诊的单侧声带不动英文成人患者,评估CoPE患者报告结局量表的信度与效度。结果显示量表内部一致性高(Cronbach α>0.91),重测组内相关系数中等(0.66-0.80),与现有量表相关性均大于0.69,作者认为CoPE可作为心理测量学可靠的UVFP相关失能综合测量工具。

要点

  • CoPE量表22个条目及心理社会、吞咽、嗓音三个亚量表内部一致性高(Cronbach α>0.91)。
  • 基线至2周重测组内相关系数中等,总体及亚量表范围为0.66-0.80。
  • 与嗓音相关生活质量、进食评估工具、交流参与条目库的相关性均大于0.69。

核心结论

  • 调查验证研究结果提示CoPE量表可作为心理测量学可靠、全面的UVFP相关失能测量工具,适用于临床与研究场景评估个体内变化。
  • 研究结果将用于制定用户手册,以促进在比较行为治疗(言语治疗)、临时治疗(如注射填充)和永久性手术治疗UVFP有效性与持久性的临床试验中使用。

研究设计与样本

  • 调查验证研究,在美国34家三级医疗中心开展。
  • 纳入经喉镜确诊单侧声带不动的英语成人患者。
  • 共招募613例患者(平均[SD]年龄58[15.3]岁;394例[64.5%]为女性),555例(92.3%)完成所有时间点调查。
  • 评估信度(内部一致性、复本信度、重测信度)与效度(聚合效度、已知组效度)。

主要发现

  • 22条目CoPE量表总体及心理社会、吞咽、嗓音亚量表内部一致性高(Cronbach α>0.91)。
  • 基线至2周个体组内相关系数总体及亚量表中等(范围0.66-0.80)。
  • 在线施测与2周后纸质施测在总体评分及嗓音、心理社会亚量表存在显著差异(总体量表均值:54.4[95%CI,49.7-59.1] vs 2周时48.9[95%CI,43.7-54.0])。
  • 验证性模型基于亚量表与总体评分平均r²值≥0.5认为拟合良好。
  • 各亚量表与现有量表(嗓音相关生活质量、进食评估工具、交流参与条目库)相关性均大于0.69,且PROM亚量表平均分在现有量表已知四分位组间存在显著差异。

临床怎么用

  • 作者认为CoPE量表可作为心理测量学可靠、全面的UVFP相关失能测量工具,适用于临床与研究场景评估个体内变化。
  • 研究结果将用于制定用户手册,以促进在比较行为治疗(言语治疗)、临时治疗(如注射填充)和永久性手术治疗UVFP有效性与持久性的临床试验中使用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Unilateral vocal fold paralysis (UVFP) is a common and life-changing complication of cancer, trauma, and an estimated 500 000 head, neck, and chest surgeries performed annually in the US, among other causes (eg, idiopathic). Consequent disabilities are profound and often permanent and can include severe voice, swallowing, and breathing dysfunction and concomitant anxiety, isolation, and fear. Physiological measures often correlate poorly with patient-reported disability. The measure described herein was designed to be a comprehensive, psychometrically sound UVFP-specific patient-reported outcome measure (PROM) for use in clinical trials or at point of care. OBJECTIVE: To evaluate the reliability and validity of the CoPE (vocal Cord Paralysis Experience) PROM in a nationally representative sample for both clinical and research use. DESIGN, SETTING, AND PARTICIPANTS: This survey validation study was performed at 34 tertiary care centers across the US and included English-speaking adults with unilateral vocal fold immobility confirmed via laryngoscopy. MAIN OUTCOMES AND MEASURES: Reliability (internal consistency, alternate form, and test-retest) and validity (convergent and known-group). RESULTS: In total, 613 patients (mean [SD] age, 58 [15.3] years; 394 [64.5%] women) were recruited, and 555 (92.3%) completed surveys for all time points. Internal consistency was high in the overall 22-item PROM and psychosocial, swallow, and voice subscales (Cronbach α > 0.91). Intraclass correlations for individuals between the baseline and 2-week administrations were moderate for the overall score and subscales (intraclass correlations range, 0.66-0.80). There were significant differences between the online and 2-week paper administrations for the overall score and voice and psychosocial subscales (overall scale mean: 54.4 [95% CI, 49.7-59.1] vs 48.9 [95% CI, 43.7-54.0] at 2 weeks). The confirmatory model was found to be suitably fitted based on average r2 values 0.5 or greater for subscale and overall scores. Correlations between subscales and existing PROMs (Voice-Related Quality of Life, Eating Assessment Tool, and Communication Participation Item Bank) were all greater than 0.69, and mean PROM subscale scores were significantly different across known quartiles of existing PROMs. CONCLUSIONS AND RELEVANCE: The findings of this survey validation study suggest that the CoPE PROM could serve as a psychometrically sound, comprehensive measure of UVFP-attributed disability suitable for use in clinical and research settings to assess within-person changes. The results will inform a user manual to facilitate use in clinical trials comparing the effectiveness and durability of treatments including behavioral (speech therapy), temporary (eg, injection augmentation), and permanent surgical treatments for UVFP.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Fernandes-Taylor S, Damico-Smith C, Arroyo N, et al. Multicenter Development and Validation of the Vocal Cord Paralysis Experience (CoPE), a Patient-Reported Outcome Measure for Unilateral Vocal Fold Paralysis-Specific Disability. JAMA Otolaryngol Head Neck Surg. 2022. PMID: 35797026. doi:10.1001/jamaoto.2022.1545

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。